NCT07860333 Mobilisation After Endovascular Stroke Treatment
| NCT ID | NCT07860333 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Karolinska Institutet |
| Condition | Stroke |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2026-05-07 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2026-05-07 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to learn how the timing of mobilisation after endovascular thrombectomy (EVT) affects complications in patients with acute ischaemic stroke. The main questions it aims to answer are: Does mobilisation approximately 12 hours after EVT, compared to approximately 24 hours after EVT, affect the risk of complications such as access site haematoma (ASH), venous thromboembolism (VTE), infections, and delirium? How common are these complications after EVT, and which factors are associated with increased risk? Participants undergoing EVT as part of their regular stroke care at two hospitals with different mobilisation routines will be followed during their hospital stay. Researchers will collect information about mobilisation timing, complications, clinical assessments, and medical history using case report forms, electronic health records, and national stroke registries.
Eligibility Criteria
Inclusion Criteria: * Undergone endovascular thrombectomy for acute ischaemic stroke * Minimum 18 years old Exclusion Criteria: * Residing from outside primary catchment area * Spending more than 24 hrs in ICU post thrombectomy
Contact & Investigator
Eric Thelin, Ass. Professor
PRINCIPAL INVESTIGATOR
Karolinska Institutet
Frequently Asked Questions
Who can join the NCT07860333 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07860333 currently recruiting?
Yes, NCT07860333 is actively recruiting participants. Contact the research team at karin.crantz@ki.se for enrollment information.
Where is the NCT07860333 trial being conducted?
This trial is being conducted at Tampere, Finland, Stockholm, Sweden.
Who is sponsoring the NCT07860333 clinical trial?
NCT07860333 is sponsored by Karolinska Institutet. The principal investigator is Eric Thelin, Ass. Professor at Karolinska Institutet. The trial plans to enroll 400 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.